144 related articles for article (PubMed ID: 36917789)
1. Novel Loss-of-Function
Vera-Zambrano A; Lago-Docampo M; Gallego N; Franco-Gonzalez JF; Morales-Cano D; Cruz-Utrilla A; Villegas-Esguevillas M; Fernández-Malavé E; Escribano-Subías P; Tenorio-Castaño JA; Perez-Vizcaino F; Valverde D; González T; ; Cogolludo A
Am J Respir Cell Mol Biol; 2023 Aug; 69(2):147-158. PubMed ID: 36917789
[TBL] [Abstract][Full Text] [Related]
2. Function of Kv1.5 channels and genetic variations of KCNA5 in patients with idiopathic pulmonary arterial hypertension.
Remillard CV; Tigno DD; Platoshyn O; Burg ED; Brevnova EE; Conger D; Nicholson A; Rana BK; Channick RN; Rubin LJ; O'connor DT; Yuan JX
Am J Physiol Cell Physiol; 2007 May; 292(5):C1837-53. PubMed ID: 17267549
[TBL] [Abstract][Full Text] [Related]
3. miR-1 is increased in pulmonary hypertension and downregulates Kv1.5 channels in rat pulmonary arteries.
Mondejar-Parreño G; Callejo M; Barreira B; Morales-Cano D; Esquivel-Ruiz S; Moreno L; Cogolludo A; Perez-Vizcaino F
J Physiol; 2019 Feb; 597(4):1185-1197. PubMed ID: 29717493
[TBL] [Abstract][Full Text] [Related]
4. Potassium channels in pulmonary arterial hypertension.
Boucherat O; Chabot S; Antigny F; Perros F; Provencher S; Bonnet S
Eur Respir J; 2015 Oct; 46(4):1167-77. PubMed ID: 26341985
[TBL] [Abstract][Full Text] [Related]
5. Notch enhances Ca
Song S; Babicheva A; Zhao T; Ayon RJ; Rodriguez M; Rahimi S; Balistrieri F; Harrington A; Shyy JY; Thistlethwaite PA; Makino A; Yuan JX
Am J Physiol Cell Physiol; 2020 May; 318(5):C954-C968. PubMed ID: 32186932
[TBL] [Abstract][Full Text] [Related]
6. Genetic variation in KCNA5: impact on the atrial-specific potassium current IKur in patients with lone atrial fibrillation.
Christophersen IE; Olesen MS; Liang B; Andersen MN; Larsen AP; Nielsen JB; Haunsø S; Olesen SP; Tveit A; Svendsen JH; Schmitt N
Eur Heart J; 2013 May; 34(20):1517-25. PubMed ID: 23264583
[TBL] [Abstract][Full Text] [Related]
7. Tetramerization domain mutations in KCNA5 affect channel kinetics and cause abnormal trafficking patterns.
Burg ED; Platoshyn O; Tsigelny IF; Lozano-Ruiz B; Rana BK; Yuan JX
Am J Physiol Cell Physiol; 2010 Mar; 298(3):C496-509. PubMed ID: 20018952
[TBL] [Abstract][Full Text] [Related]
8. Acute hypoxia selectively inhibits KCNA5 channels in pulmonary artery smooth muscle cells.
Platoshyn O; Brevnova EE; Burg ED; Yu Y; Remillard CV; Yuan JX
Am J Physiol Cell Physiol; 2006 Mar; 290(3):C907-16. PubMed ID: 16236819
[TBL] [Abstract][Full Text] [Related]
9. Association of a KCNA5 gene polymorphism with systemic sclerosis-associated pulmonary arterial hypertension in the European Caucasian population.
Wipff J; Dieudé P; Guedj M; Ruiz B; Riemekasten G; Cracowski JL; Matucci-Cerinic M; Melchers I; Humbert M; Hachulla E; Airo P; Diot E; Hunzelmann N; Caramaschi P; Sibilia J; Valentini G; Tiev K; Girerd B; Mouthon L; Riccieri V; Carpentier PH; Distler J; Amoura Z; Tarner I; Degano B; Avouac J; Meyer O; Kahan A; Boileau C; Allanore Y
Arthritis Rheum; 2010 Oct; 62(10):3093-100. PubMed ID: 20556823
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of human KCNA5 increases IK V and enhances apoptosis.
Brevnova EE; Platoshyn O; Zhang S; Yuan JX
Am J Physiol Cell Physiol; 2004 Sep; 287(3):C715-22. PubMed ID: 15140747
[TBL] [Abstract][Full Text] [Related]
11. Deficiency of NOX1/nicotinamide adenine dinucleotide phosphate, reduced form oxidase leads to pulmonary vascular remodeling.
Iwata K; Ikami K; Matsuno K; Yamashita T; Shiba D; Ibi M; Matsumoto M; Katsuyama M; Cui W; Zhang J; Zhu K; Takei N; Kokai Y; Ohneda O; Yokoyama T; Yabe-Nishimura C
Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):110-9. PubMed ID: 24233492
[TBL] [Abstract][Full Text] [Related]
12. Implication of Potassium Channels in the Pathophysiology of Pulmonary Arterial Hypertension.
Le Ribeuz H; Capuano V; Girerd B; Humbert M; Montani D; Antigny F
Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32882918
[TBL] [Abstract][Full Text] [Related]
13. Uncovered Contribution of Kv7 Channels to Pulmonary Vascular Tone in Pulmonary Arterial Hypertension.
Mondéjar-Parreño G; Barreira B; Callejo M; Morales-Cano D; Barrese V; Esquivel-Ruiz S; Olivencia MA; Macías M; Moreno L; Greenwood IA; Perez-Vizcaino F; Cogolludo A
Hypertension; 2020 Oct; 76(4):1134-1146. PubMed ID: 32829658
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia selectively inhibits KCNA5 channels in pulmonary artery smooth muscle cells.
Firth AL; Platoshyn O; Brevnova EE; Burg ED; Powell F; Haddad GH; Yuan JX
Ann N Y Acad Sci; 2009 Oct; 1177():101-11. PubMed ID: 19845612
[TBL] [Abstract][Full Text] [Related]
15. KCNA5 gene is not confirmed as a systemic sclerosis-related pulmonary arterial hypertension genetic susceptibility factor.
Bossini-Castillo L; Simeon CP; Beretta L; Broen J; Vonk MC; Callejas JL; Carreira P; Rodríguez-Rodríguez L; García-Portales R; González-Gay MA; Castellví I; Camps MT; Tolosa C; Vicente-Rabaneda E; Egurbide MV; ; Schuerwegh AJ; Hesselstrand R; Lunardi C; van Laar JM; Shiels P; Herrick A; Worthington J; Denton C; Radstake TR; Fonseca C; Martin J
Arthritis Res Ther; 2012 Dec; 14(6):R273. PubMed ID: 23270786
[TBL] [Abstract][Full Text] [Related]
16. The Impact of Heterozygous
Bohnen MS; Roman-Campos D; Terrenoire C; Jnani J; Sampson KJ; Chung WK; Kass RS
J Am Heart Assoc; 2017 Sep; 6(9):. PubMed ID: 28889099
[TBL] [Abstract][Full Text] [Related]
17. Novel mutations in BMPR2, ACVRL1 and KCNA5 genes and hemodynamic parameters in patients with pulmonary arterial hypertension.
Pousada G; Baloira A; Vilariño C; Cifrian JM; Valverde D
PLoS One; 2014; 9(6):e100261. PubMed ID: 24936649
[TBL] [Abstract][Full Text] [Related]
18. The Action of Smooth Muscle Cell Potassium Channels in the Pathology of Pulmonary Arterial Hypertension.
Hayabuchi Y
Pediatr Cardiol; 2017 Jan; 38(1):1-14. PubMed ID: 27826710
[TBL] [Abstract][Full Text] [Related]
19. Fluoxetine protects against monocrotaline-induced pulmonary arterial hypertension: potential roles of induction of apoptosis and upregulation of Kv1.5 channels in rats.
Zhai FG; Zhang XH; Wang HL
Clin Exp Pharmacol Physiol; 2009 Aug; 36(8):850-6. PubMed ID: 19298536
[TBL] [Abstract][Full Text] [Related]
20. The nuclear factor of activated T cells in pulmonary arterial hypertension can be therapeutically targeted.
Bonnet S; Rochefort G; Sutendra G; Archer SL; Haromy A; Webster L; Hashimoto K; Bonnet SN; Michelakis ED
Proc Natl Acad Sci U S A; 2007 Jul; 104(27):11418-23. PubMed ID: 17596340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
